Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Synageva BioPharma Corp. (GEVA)

-NasdaqGS

39.87 Up 0.04(0.10%) May 17, 4:00PM EDT|After Hours : 39.87 0.00 (0.00%) May 17, 4:32PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 14,954   2,099   595  
Cost of Revenue -   -   -  
Gross Profit 14,954   2,099   595  
Operating Expenses
Research Development37,347  17,346  9,866  
Selling General and Administrative17,396  9,268  3,852  
Non Recurring -   -   -  
Others3,232  504   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (43,021) (25,019) (13,123)
Income from Continuing Operations
Total Other Income/Expenses Net -  (259)2,295  
Earnings Before Interest And Taxes(42,949)(25,306)(10,824)
Interest Expense -   -   -  
Income Before Tax(42,949)(25,306)(10,824)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(42,949)(25,306)(10,824)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (42,949) (25,306) (10,824)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (42,949) (25,306) (10,824)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.